Study Summary
This study will provide long-term follow-up for patients who have received treatment with WU-CART-007 in a previous clinical trial. In this study, patients will be followed for up to 15 years after their last dose of WU-CART-007 for evaluation of delayed adverse events, presence of persisting WU-CART-007 vector sequences, and overall survival and progression-free survival.
Want to learn more about this trial?
Request More InfoInterventions
Genetic: WU-CART-007GENETIC
No study drug is administered in this study. Patients who have received WU-CART-007 will be enrolled in this study for Long Term Safety and Efficacy
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| City of Hope | Duarte | California | United States |
| Childrens Hospital LA | Los Angeles | California | United States |
| Washington University | St Louis | Missouri | United States |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | United States |
| Peter MacCullam Cancer Center | Melbourne | Australia |